Incurable Non Metastatic Hepatocellular Carcinoma clinical trials

Explore recruiting incurable non metastatic hepatocellular carcinoma clinical trials.

Recruiting incurable non metastatic hepatocellular carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Incurable Non Metastatic Hepatocellular Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK-7902) with Pembrolizumab (MK-3475) in Combination with Transarterial Chemoembolization (TACE) Versus TACE in Participants with Incurable/Non-metastatic Hepatocellular Carcinoma (LEAP-012)

Germany, Portugal, Italy, Ireland, Denmark, Spain +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Incurable Non Metastatic Hepatocellular Carcinoma trials by city

Incurable Non Metastatic Hepatocellular Carcinoma in Toronto Incurable Non Metastatic Hepatocellular Carcinoma in Vancouver Incurable Non Metastatic Hepatocellular Carcinoma in Montreal Incurable Non Metastatic Hepatocellular Carcinoma in Calgary Incurable Non Metastatic Hepatocellular Carcinoma in Edmonton Incurable Non Metastatic Hepatocellular Carcinoma in Ottawa Incurable Non Metastatic Hepatocellular Carcinoma in Winnipeg Incurable Non Metastatic Hepatocellular Carcinoma in Quebec City Incurable Non Metastatic Hepatocellular Carcinoma in Hamilton Incurable Non Metastatic Hepatocellular Carcinoma in Kitchener Incurable Non Metastatic Hepatocellular Carcinoma in London Incurable Non Metastatic Hepatocellular Carcinoma in Halifax Incurable Non Metastatic Hepatocellular Carcinoma in New York Incurable Non Metastatic Hepatocellular Carcinoma in Los Angeles Incurable Non Metastatic Hepatocellular Carcinoma in Chicago Incurable Non Metastatic Hepatocellular Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease